These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 33992439)

  • 1. Barriers and activities to implementing or expanding influenza vaccination programs in low- and middle-income countries: A global survey.
    Kraigsley AM; Moore KA; Bolster A; Peters M; Richardson D; Arpey M; Sonnenberger M; McCarron M; Lambach P; Maltezou HC; Bresee JS
    Vaccine; 2021 Jun; 39(25):3419-3427. PubMed ID: 33992439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza vaccine programs for children in low- and middle-income countries: current status and way forward.
    Ortiz JR; Neuzil KM
    Expert Rev Vaccines; 2019 Jul; 18(7):711-724. PubMed ID: 31226895
    [No Abstract]   [Full Text] [Related]  

  • 3. Shaping meeting to explore the value of a coordinated work plan for epidemic and pandemic influenza vaccine preparedness.
    Ruscio B; Bolster A; Bresee J;
    Vaccine; 2020 Apr; 38(16):3179-3183. PubMed ID: 32171576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza vaccination in the Americas: Progress and challenges after the 2009 A(H1N1) influenza pandemic.
    Ropero-Álvarez AM; El Omeiri N; Kurtis HJ; Danovaro-Holliday MC; Ruiz-Matus C
    Hum Vaccin Immunother; 2016 Aug; 12(8):2206-2214. PubMed ID: 27196006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seasonal influenza vaccination in middle-income countries: Assessment of immunization practices in Belarus, Morocco, and Thailand.
    Mantel C; Chu SY; Hyde TB; Lambach P;
    Vaccine; 2020 Jan; 38(2):212-219. PubMed ID: 31699507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs and cost-effectiveness of influenza illness and vaccination in low- and middle-income countries: A systematic review from 2012 to 2022.
    Gharpure R; Chard AN; Cabrera Escobar M; Zhou W; Valleau MM; Yau TS; Bresee JS; Azziz-Baumgartner E; Pallas SW; Lafond KE
    PLoS Med; 2024 Jan; 21(1):e1004333. PubMed ID: 38181066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015.
    Jorgensen P; Mereckiene J; Cotter S; Johansen K; Tsolova S; Brown C
    Vaccine; 2018 Jan; 36(4):442-452. PubMed ID: 29287683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza vaccination policies for health workers in low-income and middle-income countries: A cross-sectional survey, January-March 2020.
    Maltezou HC; Theodoridou K; Tseroni M; Raftopoulos V; Bolster A; Kraigsley A; Bresee J; Lambach P
    Vaccine; 2020 Nov; 38(47):7433-7439. PubMed ID: 33059970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza Immunization in Low- and Middle-Income Countries: Preparing for Next-Generation Influenza Vaccines.
    Ortiz JR; Neuzil KM
    J Infect Dis; 2019 Apr; 219(Suppl_1):S97-S106. PubMed ID: 30715348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and effectiveness of seasonal and pandemic A (H1N1) 2009 influenza vaccines in low and middle income countries: a systematic review and meta-analysis.
    Breteler JK; Tam JS; Jit M; Ket JC; De Boer MR
    Vaccine; 2013 Oct; 31(45):5168-77. PubMed ID: 24012574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seasonal influenza vaccine provision in 157 countries (2004-2009) and the potential influence of national public health policies.
    Palache A
    Vaccine; 2011 Nov; 29(51):9459-66. PubMed ID: 22024174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceptability, cost-effectiveness, and capacity of a facility-based seasonal influenza vaccination among high-risk groups: a study protocol in selected tertiary care hospitals of Bangladesh.
    Hassan MZ; Biswas MAAJ; Rahman M; Shoshi HR; Pyash AS; Islam MA; Haque MA; Parvin SR; Hossen MT; Hussain M; Rahman M; Shirin T; Chowdhury F
    BMC Public Health; 2024 Jan; 24(1):242. PubMed ID: 38245668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The partnership for influenza vaccine introduction (PIVI): Supporting influenza vaccine program development in low and middle-income countries through public-private partnerships.
    Bresee JS; Lafond KE; McCarron M; Azziz-Baumgartner E; Chu SY; Ebama M; Hinman AR; Xeuatvongsa A; Bino S; Richardson D; Porter RM; Moen A; McKinlay M;
    Vaccine; 2019 Aug; 37(35):5089-5095. PubMed ID: 31288998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A global review of national influenza immunization policies: Analysis of the 2014 WHO/UNICEF Joint Reporting Form on immunization.
    Ortiz JR; Perut M; Dumolard L; Wijesinghe PR; Jorgensen P; Ropero AM; Danovaro-Holliday MC; Heffelfinger JD; Tevi-Benissan C; Teleb NA; Lambach P; Hombach J
    Vaccine; 2016 Oct; 34(45):5400-5405. PubMed ID: 27646030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ancillary benefits of seasonal influenza vaccination in middle-income countries.
    Ebama MS; Chu SY; Azziz-Baumgartner E; Lafond KE; McCarron M; Hadler SC; Porter RM; McKinlay M; Bresee J
    Vaccine; 2021 Apr; 39(14):1892-1896. PubMed ID: 33714656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
    Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
    Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quadrivalent influenza vaccines in low and middle income countries: Cost-effectiveness, affordability and availability.
    Hendriks J; Hutubessy RCW; Grohmann G; Torelli G; Friede M; Kieny MP
    Vaccine; 2018 Jun; 36(28):3993-3997. PubMed ID: 29866617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developing a seasonal influenza vaccine recommendation in Kenya: Process and challenges faced by the National Immunization Technical Advisory Group (NITAG).
    Dawa J; Chaves SS; Ba Nguz A; Kalani R; Anyango E; Mutie D; Muthoka P; Tabu C; Maritim M; Amukoye E; Were F;
    Vaccine; 2019 Jan; 37(3):464-472. PubMed ID: 30502070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza in the Asia-Pacific region: Findings and recommendations from the Global Influenza Initiative.
    Cowling BJ; Caini S; Chotpitayasunondh T; Djauzi S; Gatchalian SR; Huang QS; Koul PA; Lee PI; Muttalif AR; Plotkin S;
    Vaccine; 2017 Feb; 35(6):856-864. PubMed ID: 28081970
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.